Posted on 23-July-2022
Knee implants are metal devices that are implanted into the knee to help strengthen it. They are usually used to treat osteoarthritis, but can also be used to treat other conditions. Knee implants are artificial joints used to replace the natural joints in the knee. They are used by people who have suffered from arthritis in their knees. The knee implant is inserted into the patient's knee and it replaces damaged cartilage with an artificial one.
Knee implants are used in orthopedic procedures such as anterior cruciate ligament (ACL) reconstruction and meniscus repair. They are typically implanted in the patellar (knee cap) or tibial (shin bone) areas of the knee joint. Knee implants are also known as Osseo integrated fixation devices because there is no chance of infection through bone grafting with these implants.
The knee implant market has been witnessing an increasing demand for replacement and resurfacing surgeries, which have increased due to rising cases of osteoarthritis (OA) among the aging population. In addition, the increase in the prevalence of obesity across all age groups is likely to drive the demand for knee replacement surgery in the near future.
According to the report, the knee implant market is expected to grow at a CAGR of 6% from 2022 to 2027.
The key players in this market include B. Braun, Smith & Nephew, Zimmer Biomet Holding Inc., Stryker, Exactech, Johnson & Johnson, DJO Surgical, Medtronic, Becton Dickinson
Knee implants Market Types and applications:
Knee implants can be used in various applications such as total knee replacement (TKR) or arthroplasty procedures. They are also used during hip replacement surgeries or other orthopedic procedures such as hip resurfacing surgeries or acetabular reconstruction surgeries. The first use of this technology was around 1965 when it was used in total hip replacement surgeries; however, it has been extensively used over time due to its benefits over.
The implant market is segmented by type of implant and by application. The majority of implants are used in the treatment of osteoarthritis, but they can also be used to treat other conditions. The largest segment of the knee implant market is comprised of total knee replacements, which accounted for over 60% of revenue in 2012. Other types include prosthetic hips, hip resurfacing, and total hip replacement.
The major factors driving this market include the rising prevalence of arthritis among the population, high demand for affordable health care, and increasing awareness about knee joint replacement.
The growth of the market is driven by factors such as the aging population, increasing prevalence of osteoarthritis, rising prevalence of obesity, an increasing number of surgeries performed on knees due to injuries caused by accidents, sports injuries, and other diseases such as diabetes.
The knee implant market has been segmented into three categories: total knee replacement (TKR), stem cell therapy for osteoarthritis (OSTA), and total hip replacement (THR). Total knee replacement (TKR) accounted for over 60% share in 2017. Stem cell therapy for OTA accounted for over 15% share in 2017. Total hip replacement (THR) accounted for around 25% share in 2017.
Also, read related topics: